ACTR3BP5 and cancer: HHIPL2, XPO1, SALRNA1, ZBTB45, ANP32AP1, ACTR3BP5, LOC100129138, GPR45, and CAB39L gene deletions were associated with non-cancer subjects without FCH (p < 0.05), while RAB9BP1, LOC101928523, and MALRD1 gene deletions were related to non-cancer patients with FCH (p < 0.05).